Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Similar documents
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Cardiology Department Coimbra Hospital and Medical School Portugal

Patient characteristics Intervention Comparison Length of followup

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Alex versus Xience Registry Preliminary report

Supplementary Material to Mayer et al. A comparative cohort study on personalised

PROMUS Element Experience In AMC

Supplement materials:

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

SUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index

Early discharge in selected patients after an acute coronary syndrome can it be safe?

4. Which survey program does your facility use to get your program designated by the state?

Cronicon CARDIOLOGY. N Laredj*, HM Ali Lahmar and L Hammou. Abstract

Abstract Background: Methods: Results: Conclusions:

Quality Payment Program: Cardiology Specialty Measure Set

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Statistical analysis plan

INTRODUCTION. Key Words:

Quality Payment Program: Cardiology Specialty Measure Set

Lessons learned From The National PCI Registry

Supplementary Appendix

Patient referral for elective coronary angiography: challenging the current strategy

Exercise treadmill testing is frequently used in clinical practice to

Supplementary Appendix

Supplementary Online Content

Importance of the third arterial graft in multiple arterial grafting strategies

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

The prognostic role of serum uric acid level in patients with acute ST elevation myocardial infarction

SUPPLEMENTAL MATERIAL

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

The MAIN-COMPARE Study

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.

Stable Angina: Indication for revascularization and best medical therapy

Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction

Supplementary Online Content

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Coronary artery disease (CAD) risk factors

APPENDIX F: CASE REPORT FORM

Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score

Rita Calé, Miguel Mendes, António Ferreira, João Brito, Pedro Sousa, Pedro Carmo, Francisco Costa, Pedro Adragão, João Calqueiro, José Aniceto Silva.

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

egfr > 50 (n = 13,916)

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Statin pretreatment and presentation patterns in patients with acute coronary syndromes

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

ESC CONGRESS Munich, Germany, August. Compliance to a Cardiac Rehabilitation Program: what are the benefits and impact on prognosis?

The MAIN-COMPARE Registry

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Acute Myocardial Infarction

Acute Myocardial Infarction Treatment of Young versus Elderly patients: Insights from the Leiden MISSION! program.

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Online Appendix (JACC )

Cafri C; Zahger D; Rosenshtein G, Kleshian I; Ilia R

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

DUKECATHR Dataset Dictionary

A Prior Myocardial Infarction: How Does it Affect Management and Outcomes in Recurrent Acute Coronary Syndromes?

Downloaded from:

CLINICAL COURSE, MANAGEMENT AND IN-HOSPITAL OUTCOMES

Consensus Core Set: Cardiovascular Measures Version 1.0

Characteristics of Transient ST-Elevation versus ST-Elevation and Non-ST-Elevation Myocardial Infarction

Impact of Body Mass Index on In-Hospital Outcomes after Percutaneous Coronary Intervention

Compliance of pharmacological treatment for non-st-elevation acute coronary syndromes with contemporary guidelines: influence on outcomes

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Impact of Body Mass Index on Long-Term All-Cause Mortality after Percutaneous Coronary Intervention in African-Americans

Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

Particularities of Coronary Artery Disease in Hypertensive Patients with Left Bundle Branch Block Larisa ANGHEL a ; Catalina ARSENESCU GEORGESCU a,b

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

The Author(s) This article is published with open access by ASEAN Federation of Cardiology

Ischemic Heart Disease Interventional Treatment

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

HEART RATE IN PATIENTS WITH CORONARY ARTERY DISEASE IN LATVIA

Journal of the American College of Cardiology Vol. 46, No. 8, by the American College of Cardiology Foundation ISSN /05/$30.

Hyeon-Cheol Gwon, On the behalf of SMART-DATE trial investigators ACC LBCT 2018

Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan

Kavitha Yaddanapudi Stony brook University New York

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Supplementary Online Content

DECLARATION OF CONFLICT OF INTEREST

The ESC Registry on Chronic Ischemic Coronary Disease

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Supplementary Table S1: Proportion of missing values presents in the original dataset

Background- Methods and Results- Conclusion-

Journal of the American College of Cardiology Vol. 50, No. 11, by the American College of Cardiology Foundation ISSN /07/$32.

Rehospitalization Prognostic Factors in Patients with Heart Failure: a Prospective Follow-up Study

Long-Term Percutaneous Coronary Intervention Outcomes of Patients with Chronic Kidney Disease in the Era of Second-Generation Drug-Eluting Stents

Development of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Transcription:

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João Correia, José Monge, José Azevedo, Isabel Arroja, Ana Aleixo, Miguel Mendes

Conflicts of interest: none

Introduction (1) Aim Methods Results Conclusions Obesity has reached epidemic proportions in the western countries: - Prevalence is trending upward - Risk factor for coronary disease and acute coronary syndrome (ACS) - Association with cardiovascular (CV) and non-cv mortality (general population)

Introduction (2) Aim Methods Results Conclusions Contradictory evidence in patients with established coronary artery disease (CAD) Obesity paradox? Conditions in which obesity has been associated with favourable prognosis First elective PCI n=9578 All-cause death 5-years

Aim Cardiology Department Introduction Methods Results Conclusions To assess the extension of coronary disease and the prognosis of patients with ACS according to the Body Mass Index (BMI)

Introduction Aim Methods (1) Results Conclusions Retrospective analysis Consecutive patients admitted with ACS in a Coronary Unit (Jan/03-Jan/04) Categorization of the patients according to the BMI * (kg/m 2 ) category (WHO * ): Underweight (<18.5 ) Normal weight (18.5-24.9) Overweight (25.0-29.9) Obesity ( 30.0) * WHO World Health Organization

Aim Methods (2) Introduction Results Conclusions Variables Demographic: Age and gender Clinical: CV risk factors (Hypertension, Diabetes Mellitus, Smoking, Dyslipidemia), past history [Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG), Stroke/Transient Ischemic Accident (TIA)] and clinical presentation (height, weight, blood pressure, heart rate, Killip class) Electrocardiographic: ST deviation, T wave inversion Echocardiographic: Left Ventricular Ejection Fraction (LVEF) Angiographic: Number of significant coronary artery stenosis (>50% lumen obstruction) Therapeutic: Reperfusion (PCI, Thrombolysis and CABG) and therapy at discharge

Introduction Aim Methods (3) Results Conclusions Comparison of the variables registered between the BMI categories Survival analysis and evaluation of the correlation between BMI and all-cause mortality at 30-days, 12 -months and 5-years of follow-up Statistical analysis (SPSS v18.0) Qualitative variables (numbers and percentages) compared by chi-square test continuous variables by t-student (m±sd) (Kolmogorov-Smirnov normality tested) Logistic regression (OR, 95% CI) comparing patients variables: BMI 24.9 vs 25.0 kg/m 2 Multivariate binary logistic regression - correlation between BMI and multivesel lesions Cox regression analysis to evaluate the association between BMI and all-cause mortality Survival analysis by the Kaplan-Meier method (Log-Rank test to evaluate differences) Statistical significance - p value <0.05

Aim Results (1) Introduction Methods Conclusions Baseline characteristics n = 270 patients Age (m±sd) = 64.8±12.2 years 67.8% (183) male NSTEMI - 38.5% (104) STEMI - 36.3% (98) UA - 25.2% (68) BMI category (%)* BMI (m±sd) = 27.4±4.1 kg/m 2 * No patients underweight

Aim Results (2) Introduction Methods Conclusions Baseline characteristics Variables (%) BMI 24.9 (n=59) p value BMI 25.0 29.9 (n=145) p value BMI 30.0 (n=66) Age (m±sd) 66.9±11.8 0.310 65.0±12.1 0.147 62.2±12.1 Age >75 years 28.8 0.064 17.2 0.547 13.8 Male gender 64.4 0.257 72.4 0.093 60.3 Hypertension 50.8 0.003 72.4 0.309 79.3 Diabetes Mellitus 22.0 0.600 25.5 0.199 34.5 Dyslipidemia 39.0 0.195 49.0 0.564 53.4 Smoking 40.7 0.222 31.7 0.563 27.6 Stroke/TIA 5.1 0.939 4.8 0.918 5.2 Prior AMI 27.1 0.813 25.5 0.838 24.1 Prior PCI 8.5 0.684 10.3 0.446 6.9 Prior CABG 6.8 0.728 5.5 0.415 8.6

Introduction Aim Methods Results (3) Conclusions Baseline characteristics Variables (%) BMI 24.9 (n=59) p value BMI 25.0 29.9 (n=145) p value BMI 30.0 (n=66) STEMI 42.4 0.289 34.5 0.816 36.2 NSTEMI 39.0 0.965 39.3 0.522 34.5 UA 18.6 0.252 26.2 0.653 29.3 SBP (m±sd) 151.8±29.0 0.547 154.7±35.3 0.215 148.3±32.0 Heart rate (m±sd) 78.2±20.5 0.685 79.5±21.7 0.201 84.1±24.3 Killip class > I 19.6 0.660 16.9 0.839 18.2 ECG ST-elevation 40.7 0.481 35.4 0.916 36.2 ST-depression 35.6 0.127 25.0 0.898 24.1 Isolated T wave inversion 10.2 0.023 24.3 0.817 25.9 Normal 11.9 0.797 13.2 0.910 13.6 LVEF (m±sd) 61.0±16.3 0.41 58.8±14.2 0.161 55.3±16.9 ECG Electrocardiogram; SAP Systolic Arterial Pressure; STEMI /NSTEMI ST Elevation/Non Myocardial Infarction; UA Unstable Angina.

Introduction Angiographic characteristics Aim Methods Results (4) Conclusions Variables (%) BMI 24.9 (n=59) p value BMI 25.0 29.9 (n=145) p value BMI 30.0 (n=66) Angiography 78 0.745 80 0.009 94.8 Left main 6.5 0.386 3.4 0.123 9,1 Left anterior descending 65.2 0.015 44.0 0.001 70.9 Left circunflex 34.8 0.946 35.3 0.418 29.1 Right coronary 67.4 0.001 38.8 0.203 49.1 Without significant lesions 10.9 0,042 27.1 0.182 17.5 One-vessel lesion 39.1 0.575 43,2 0.624 42.1 Multivessel lesions 50.0 0.013 29.7 0.082 40.4 Logistic regression (predictors of multivessel lesions) Variables OR 95% CI p value Overweight 0.39 [0.19-0.80] 0.010 Diabetes Mellitus 2.58 [1.20-5.66] 0.016 Adjusted for gender, age > 75 years and cardiovascular risk factors (dyslipidemia, Diabetes Mellitus, Hypertension)

Introduction Aim Methods Results (5) Conclusions In-hospital management Variables (%) BMI 24.9 (n=59) p value BMI 25.0 29.9 (n=145) p value BMI 30.0 (n=66) Thrombolysis * 30.5 0.404 24.8 0.531 20.7 PCI 46.8 0.427 40.8 0.029 57.4 In-hospital death 5.1 0.765 4.1 0.395 1.7 Statins + 90.7 0.949 90.4 0.167 83.3 βb + 72.2 0.936 72.8 0.328 79.6 ACE-I/ARB + 72.2 0.747 69.9 0.173 79.6 Eligible patients; + Therapy at discharge ACE-I angiotensin-converting enzyme inhibitor; ARB angiotensin receptor blocker; β B Beta bloker.

Introduction Aim Methods Results (6) Conclusions Logistic regression: BMI 24.9 vs BMI 25.0 Kg/m 2 Unadjusted model Variables OR * 95% CI p value Hypertension 3.08 [1.54-6.14] 0.001 Isolated T-wave inversion 3.97 [1.32-11.92] 0.014 Multivessel lesions 0.5 [0.25-0.98] 0.044 OR for IMC > 25.0 Kg/m 2

Aim Results (7) Introduction Methods Conclusions Correlation between BMI and all-cause mortality (Cox regression) Unadjusted model (univariate) BMI HR 95% CI p value 30-days 0.9 [0.78-1.09] 0.34 12-months 0.9 [0.79-1.08] 0.30 5-years 0.9 [0.79-1.02] 0.10 Adjusted model (multivariate) * BMI HR 95% CI p value 30-days - - - 12-months 0.9 [0.66-1.25] 0.57 5-years 0.9 [0.76-1.08] 0.24 * Adjustment for age, gender and confounders [cardiovascular risk factors, clinical presentation, LVEF and angiographic findings]

Aim Results (8) Introduction Methods Conclusions Independent predictors of all-cause mortality (Cox regression * ) Variables (%) HR 95% CI p value 30-days - - - - 12-months LVEF 0.91 [0.85-0.99] 0.023 5-years LVEF 0.96 [0.93-1.00] 0.025 * Adjustment for age, gender and confounders [cardiovascular risk factors, clinical presentation, LVEF and angiographic findings]

Introduction Aim Methods Results (9) Conclusions Survival analysis (Kaplan-Meier curves) BMI categories Normal Overweight Obesity BMI 25.0 <25.0 Time (days) 25.0 Kg/m 2 Log-Rank test (p) Time BMI categories BMI 24.9 vs Events (%/n) 30-days 0.353 0.829 4.8/11 12-months 0.852 0.656 5.6/13 5-years 0.480 0.337 11.0/22

Aim Results Conclusions (1) Introduction Methods 1) In the studied population, patients with normal BMI had more extensive CAD Paradoxically, overweight seems to have exerted a protective effect 2) Obese patients were more likely to underwent coronary angiography and PCI 3) These differences were not reflected in the prognosis (short, medium or long-term) 4) BMI was not an independent predictor for all-cause mortality

Aim Results Conclusions (2) Introduction Methods The question of which measure of obesity better predicts survival in patients with coronary artery disease remains controversial It is crucial to improve the understanding of the relationship between excess weight and cardiovascular outcomes

Aim Results Conclusions (3) Introduction Methods Limitations - Retrospective analysis - Small dimension of the sample - Duration of obesity, body-fat distribution and percentage were not quantified - Temporal weight changes during the follow-up were not valued (BMI reflects global adiposity)

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João Correia, José Monge, José Azevedo, Isabel Arroja, Ana Aleixo, Miguel Mendes Thanks

Introduction Aim Methods Results Conclusions Severity of angiographic coronary stenosis and BMI n=46663 (PCI) Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography. Rubinshtein R, Halon DA, Jaffe R, Shahla J, Lewis BS. n=928 Advancing age, male gender, diabetes mellitus and hyperlipidemia were independent predictors of high-risk anatomy, whereas obesity remained a significant negative independent predictor. n=9146 (PCI)

Introduction Aim Methods Results Conclusions n=770 (ACS)